| The Nanobiotechnology group is engaged in exploring various biomachineries
existing in organic world and identifying useful nanobio systems that
can be capitalized on. These nano systems are simplified and then
chemically realized. Application of the new methodologies developed
in this process to biological systems can lead to much enhanced applicability
into biomedicine fields. This will undoubtedly contribute to new fact
finding in science. The realized systems are ultimately to be commercialized
as devices and equipments.
Research projects currently undergoing include nonabiochip, bio-NEMS
(nanoelectromechanical system), nanobiofactory, etc. In nanobiochip
field biochips are under development, which enjoy unparalleled sensitivity
and reliability, while in bio-NEMS micromachines for clinical diagnosis
and treatment are under extensive study. The nanobiofactory field,
aiming to establish a micromolecular factory that produces bioactive
materials, pursues extensive researches based on the genuine technologies
already attained. Additionally, basic researches to accumulate fundamental
understanding of nanobiotechnology as well as chemical biology,
nanochimotransmitter, and single-cell biomolecular technology are
to be pursued.
Genuine technologies derived from each area of research are core
technologies leading the biotechnology industry and thus are expected
to produce patents whose commercialization would take relatively
short period of time. Also, since they are fundamental technologies
they can be readily linked with a variety of leading-edge bio products.
|
Nano
Bio 